| |
| |
|
| Insider
Information: |
Gaynor Richard |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
3 |
|
| Direct
Shares |
48,171 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$941,556 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
48,171 |
|
|
| Total
Value |
$941,556 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Neon Therapeutics, Inc. |
NTGN |
President of R&D |
2020-05-06 |
0 |
2019-02-27 |
0 |
Premium* |
|
|
Alkermes Plc |
ALKS |
Director |
2023-07-07 |
20,356 |
2021-05-20 |
0 |
Premium* |
|
|
Zai Lab Ltd |
ZLAB |
|
2023-06-29 |
27,815 |
2023-06-29 |
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
15 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| ALKS |
Alkermes Plc |
Director |
• • – |
2023-07-07 |
4 |
D |
$29.88 |
$42,728 |
D/D |
(1,430) |
20,356 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2023-07-07 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,957 |
21,786 |
0 |
- |
|
| ZLAB |
Zai Lab Ltd |
|
– • – |
2023-06-29 |
4 |
A |
$26.45 |
$499,984 |
D/D |
18,903 |
27,815 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-06-14 |
4 |
D |
$27.19 |
$18,897 |
D/D |
(695) |
15,829 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2022-06-14 |
4 |
OE |
$0.00 |
$0 |
D/D |
7,585 |
16,524 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-12-02 |
4 |
D |
$22.11 |
$29,605 |
D/D |
(1,339) |
8,939 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-12-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
5,578 |
10,278 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-05-20 |
4 |
D |
$21.92 |
$30,776 |
D/D |
(1,404) |
4,700 |
0 |
- |
|
| ALKS |
Alkermes Plc |
Director |
• • – |
2021-05-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
6,104 |
6,104 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
President of R&D |
• – – |
2020-05-06 |
4 |
D |
$0.00 |
$0 |
D/D |
(210,410) |
0 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
President of R&D |
• – – |
2020-02-29 |
4 |
D |
$1.50 |
$8,438 |
D/D |
(5,625) |
210,410 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
President of R&D |
• – – |
2020-02-25 |
4 |
D |
$1.51 |
$8,252 |
D/D |
(5,465) |
216,035 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
President of R&D |
• – – |
2020-01-12 |
4 |
A |
$0.00 |
$0 |
D/D |
65,000 |
221,500 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
President of R&D |
• – – |
2019-11-25 |
4 |
A |
$0.00 |
$0 |
D/D |
75,000 |
221,822 |
0 |
- |
|
| NTGN |
Neon Therapeutics, Inc. |
President of R&D |
• – – |
2019-02-27 |
4 |
A |
$0.00 |
$0 |
D/D |
57,500 |
146,822 |
0 |
- |
|
15 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
